Regular packed cell transfusion in patients with thalassemia major leads to iron overload. Chelation therapy is one of the important aspects of thalassemia care as iron overload causes significant cardiac, hepatic, and endocrine dysfunction. We report a case of thalassemia major with severe iron overload causing cardiac and liver dysfunction who benefitted from triple drug chelation therapy. Triple iron chelation therapy in thalassemia major could be suggested in severe iron overload patients.
|Number of pages||3|
|Journal||Iranian Journal of Blood and Cancer|
|Publication status||Published - 06-2021|
All Science Journal Classification (ASJC) codes